Mualliflar

  • Омашарифа бинти Жамал По.
  • Сыдиков А.А.

##semicolon##

склероатрофический лихен; иммуногистохимия; CD31; VEGF; CD95; эндотелий; плоскоклеточный рак кожи.

##submission.citations##

1. Powell J.J., Wojnarowska F. Lichen sclerosus // Lancet. 1999. Vol. 353(9166). P. 1777-1783.

2. Edmonds E., Barton G., Buisson S. et al. Gene expression profiling in male genital lichen sclerosus // Int. J. Exp. Pathol. 2011. Vol. 92(5). P. 320-325.

3. Edmonds E.V., Oyama N., Chan I. et al. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus // Br. J. Dermatol. 2011. Vol. 165(1). P. 218-219.

4. Tran D.A., Tan X., Macri C.J. et al. Lichen sclerosus: an autoimmunopathogenic and genomic enigma with emerging genetic and immune targets // Int. J. Biol. Sci. 2019. Vol. 15(7). P. 1429-1439.

5. Liegl B., Regauer S. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia // Histopathology. 2006. Vol. 48(3). P. 268-274.

6. Sander C.S., Ali I., Dean D. et al. Oxidative stress is implicated in the pathogenesis of lichen sclerosus // Br. J. Dermatol. 2004. Vol. 151(3). P. 627-635.

7. Zannoni G.F., Faraglia B., Tarquini E. et al. Expression of the CDK inhibitor p27kip1 and oxidative DNA damage in non-neoplastic and neoplastic vulvar epithelial lesions // Mod. Pathol. 2006. Vol. 19(4). P. 504-513.

8. Wang L., Yi J.L., Chen H.Y. et al. Level of Foxp3, DNMTs, methylation of Foxp3 promoter region, and CD4+CD25+CD127low regulatory T cells in vulvar lichen sclerosus // Kaohsiung J. Med. Sci. 2021. Vol. 37(6). P. 520-527.

9. Zhao Y., Zhao S., Li H. et al. Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts // Oncol. Lett. 2018. Vol. 16(2). P. 2559-2564.

10. Micheletti L., Preti M., Radici G. et al. Vulvar lichen sclerosus and neoplastic transformation: a retrospective study of 976 cases // J. Low. Genit. Tract. Dis. 2016. Vol. 20(2). P. 180-183.

11. Kirtschig G., Becker K., Günthert A. et al. Evidence based (S3) guideline on (anogenital) lichen sclerosus // J. Eur. Acad. Dermatol. Venereol. 2015. Vol. 29. P. e1-e43.